Both in Pharmaceuticals
Foghorn Therapeutics vs Organogenesis Holdings
Over the past year FHTX returned −50.9% and ORGO returned −76.7%; their daily moves had a correlation of 0.21.
FHTX −50.9% ORGO −76.7%Growth of $1, one year, split-adjusted
| Metric | FHTX | ORGO |
|---|---|---|
| Price | $2.00 | $0.9932 |
| Market cap | $118.8M | $127.8M |
| Today | −0.50% | −3.57% |
| 1 month | −44.4% | −30.1% |
| 6 months | −62.3% | −57.7% |
| Year to date | −63.0% | −80.8% |
| 1 year | −50.1% | −75.7% |
| Revenue growth (YoY) | +112.7% | −56.7% |
| Gross margin | 100.0% | 100.0% |
| Net margin | −44.7% | −227.0% |
| P/E (TTM) | — | — |
| Price / sales | 3.2× | 0.3× |
| Net cash | $167.6M | $34.4M |
| Dividend yield | — | — |
| Volatility (60d) | 106.2% | 72.7% |
| Short % of float | 6.4% | 20.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).